Home » Topics » BioWorld Science

BioWorld Science
RSS

Menorest approved in Belgium

Oct. 18, 1996

Serono's recombinant human growth hormone approved

Oct. 18, 1996

JT and Tularik to develop new antidiabetic agents

Oct. 18, 1996

Novo Nordisk enters collaboration on PTPase inhibitors

Oct. 18, 1996

Medical breakthroughated to HEV vaccines and diagnosis reported

Oct. 18, 1996

RiboGene receives further funding for HCV

Oct. 18, 1996

Joint venture to develop Exten's artificial liver technology

Oct. 18, 1996

Tokyo Tanabe discloses agents for the treatment of diarrhea

Oct. 18, 1996

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Astra-CSL collaboration for H. pylori immunotherapeutic

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.